Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Semiconductors, Circuits & Optics
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Bionano Genomics Inc. is currently managing 3 pending office actions within the Semiconductors, Circuits & Optics technology area. These 3 actions are spread across 3 distinct examiners and 3 distinct art units. This one-to-one ratio between actions, examiners, and art units indicates a diverse set of technologies or a broad application of its core intellectual property across the Semiconductors, Circuits & Optics field.
DEVITO, ALEX T is the busiest examiner for the portfolio, though they only handle 1 pending office action. Because each of the 3 distinct examiners is responsible for exactly one of the 3 pending office actions, no single examiner dominates the company's current prosecution landscape. The involvement of 3 distinct art units suggests that the filings are being reviewed by multiple specialized groups. This distribution means that the outcome of 1 pending office action will not necessarily influence the others, as they are being reviewed by 3 distinct examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Double-patenting only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DEVITO, ALEX T | 1 | 72.1% | +12.3% |
| GERIDO, DWAN A | 1 | 58.1% | +30.3% |
| YU, DELPHINUS DOU YI | 1 | 37.5% | +71.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15734918 | LABELING OF DNA | YU, DELPHINUS DOU YI | 12d |
| 18810371 | INTEGRATED ANALYSIS DEVICES AND RELATED FABRICATION METHODS AND ANALYSIS TECHNIQUES | DEVITO, ALEX T | — |
| 17690961 | PHOTOCLEAVAGE METHOD AND APPARATUS TO CLEAN FLUIDIC DEVICES | GERIDO, DWAN A | — |
| Art Unit | Apps |
|---|---|
| 2855 | 1 |
| 1797 | 1 |
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18810371 | INTEGRATED ANALYSIS DEVICES AND RELATED FABRICATION METHODS AND ANALYSIS TECHNIQUES | DEVITO, ALEX T | 2855 | DP | Non-Final OA | — | Pending | Aug 20, 2024 |
| 17690961 | PHOTOCLEAVAGE METHOD AND APPARATUS TO CLEAN FLUIDIC DEVICES | GERIDO, DWAN A | 1797 | §103 | Final Rejection | — | Pending | Mar 09, 2022 |
| 15734918 | LABELING OF DNA | YU, DELPHINUS DOU YI | 1636 | §103 | Final Rejection | 12d | Pending | Dec 03, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBionano Genomics Inc. has 3 pending office actions as of November 2026, spread across 3 art units and 3 examiners.
Alex T Devito has the most, with 1 of Bionano Genomics Inc.'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.